Literature DB >> 7670471

Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia.

J T Hecht1, L D Nelson, E Crowder, Y Wang, F F Elder, W R Harrison, C A Francomano, C K Prange, G G Lennon, M Deere.   

Abstract

Pseudoachondroplasia (PSACH) is a well characterized dwarfing condition mapping to chromosome 19p12-13.1. Cartilage oligomeric matrix protein (COMP), a cartilage specific protein, maps to the same location within a contig that spans the PSACH locus. Using single strand conformation polymorphism (SSCP) analysis and nucleotide sequencing we have identified COMP mutations in eight familial and isolated PSACH cases. All mutations involve either a single base-pair change or a three base-pair deletion in exon 17B. Six mutations delete or change a well conserved aspartic acid residue within the calcium-binding type 3 repeats. These results demonstrate that mutations in the COMP gene cause pseudochondroplasia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670471     DOI: 10.1038/ng0795-325

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  105 in total

1.  A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy.

Authors:  C G Bönnemann; G F Cox; F Shapiro; J J Wu; C A Feener; T G Thompson; D C Anthony; D R Eyre; B T Darras; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling.

Authors:  Kurt D Hankenson; Mariya T Sweetwyne; Hailu Shitaye; Karen L Posey
Journal:  Curr Osteoporos Rep       Date:  2010-06       Impact factor: 5.096

3.  A report of an Indian boy with a delayed diagnosis of pseudochondroplasia.

Authors:  Ankur Singh; T Abiramalatha; Gaurav Pradhan; Dong-Kyu Jin; Seema Kapoor
Journal:  J Clin Diagn Res       Date:  2013-07-01

Review 4.  Progranulin: a growth factor, a novel TNFR ligand and a drug target.

Authors:  Chuan-ju Liu; Xavier Bosch
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

Review 5.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

6.  ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein.

Authors:  Chuan-Ju Liu; Wei Kong; Kiril Ilalov; Shuang Yu; Ke Xu; Lisa Prazak; Marc Fajardo; Bantoo Sehgal; Paul E Di Cesare
Journal:  FASEB J       Date:  2006-04-03       Impact factor: 5.191

7.  Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein.

Authors:  Joseph L Alcorn; Thomas M Merritt; Mary C Farach-Carson; Huiqui H Wang; Jacqueline T Hecht
Journal:  RNA       Date:  2009-02-23       Impact factor: 4.942

8.  The distribution patterns of COMP and matrilin-3 in septal, alar and triangular cartilages of the human nose.

Authors:  Paul Severin Wiggenhauser; Silke Schwarz; Nicole Rotter
Journal:  Histochem Cell Biol       Date:  2018-05-02       Impact factor: 4.304

Review 9.  COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasia.

Authors:  Jason Kennedy; Gail Jackson; Simon Ramsden; Jacky Taylor; William Newman; Michael J Wright; Dian Donnai; Rob Elles; Michael D Briggs
Journal:  Eur J Hum Genet       Date:  2005-05       Impact factor: 4.246

10.  The Kathryn O. and Alan C. Greenberg Center for Skeletal Dysplasias: an interdisciplinary approach.

Authors:  Erin M Carter; Lorraine Montuori; Jessica G Davis; Cathleen L Raggio
Journal:  HSS J       Date:  2008-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.